Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells.
Gao W, Wang M, Wang L, Lu H, Wu S, Dai B, Ou Z, Zhang L, Heymach JV, Gold KA, Minna J, Roth JA, Hofstetter WL, Swisher SG, Fang B.
Gao W, et al. Among authors: dai b.
J Natl Cancer Inst. 2014 Sep 10;106(9):dju204. doi: 10.1093/jnci/dju204. Print 2014 Sep.
J Natl Cancer Inst. 2014.
PMID: 25214559
Free PMC article.